Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission
Open Access
- 14 July 2020
- journal article
- research article
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 18 (1) , 1-12
Abstract
Background Juvenile Idiopathic Arthritis (JIA) is one of the most common chronic diseases of childhood that often persists into adulthood and can result in significant long-term morbidity. As a long lasting chronic inflammatory disease, concern has been raised regarding the risk of premature development of cardiovascular disease (CVD) in JIA. This study aims to determine whether adults with JIA in clinical remission display clinical and subclinical signs of CVD risk: inflammatory mediators, adipokines, endothelial dysfunction and oxidative stress markers. Methods This is a cross-sectional study including 25 patients diagnosed with JIA according to the International League of Associations for Rheumatology criteria (ILAR 2001) and 25 age- and sex-matched controls. Remission was determined by JADAS10 < 1 and according to Wallace criteria. The presence of traditional CVD risk factors was analyzed. An extensive clinical analysis including body mass index (BMI), lipid profile, homeostatic model assessment – insulin resistance (HOMA-IR) and arterial blood pressure was performed. Intima media thickness of the common carotid artery (CIMT) was measured as a marker of subclinical atherosclerosis. Several proinflammatory cytokines, molecules involved in the endothelial dysfunction, oxidative stress and adipokines were quantified on serum by ELISA and on peripheral blood mononuclear cells (PBMCs) by RT-PCR. In vitro studies were carried out in healthy PBMCs, adipocytes and endothelial cells which were treated with serum from JIA patients under sustained remission. Results Mean duration of the disease was 13.47 ± 5.47 years. Mean age was 25.11 ± 7.21. Time in remission was 3.52 ± 3.33 years. Patients were in remission with no treatment (40%) and with treatments (60%). CVD risk factors and CIMT were similar in JIA patients and controls. However, cholesterol levels were significantly elevated in JIA patients. Levels of adipocytokines, oxidative stress and endothelial activation markers were elevated in serum and PBMCs from JIA patients. Serum of those JIA patients induced the activation of adipocytes, endothelial cells and healthy PBMCs. Conclusions JIA adult patients in remission have subclinical signs of inflammation and CVD risk, showed by an increase in the levels of inflammatory cytokines, endothelial activation and oxidative stress markers and adipokines, molecules closely involved in the alteration of the vascular system.Keywords
All Related Versions
Funding Information
- Spanish Society of Pediatric Rheumatology (Moving4 grant)
This publication has 45 references indexed in Scilit:
- Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implicationsBMJ, 2018
- Aortic, carotid intima-media thickness and flow- mediated dilation as markers of early atherosclerosis in a cohort of pediatric patients with rheumatic diseasesClinical Rheumatology, 2017
- Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritisAnnals of the Rheumatic Diseases, 2016
- Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cellsInternational Journal of Obesity, 2014
- Elevated Serum Resistin in Juvenile IdiopathicArthritis: Relation to Categories and Disease ActivityJournal of Clinical Immunology, 2012
- Carotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-AnalysisSeminars in Arthritis and Rheumatism, 2011
- Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular preventionVascular Health and Risk Management, 2009
- Role of Inflammation in Atherosclerosis Associated with Rheumatoid ArthritisThe American Journal of Medicine, 2008
- Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*Journal Of Hypertension, 2005
- The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesityNature Medicine, 2001